loading

Astrazeneca PLC 주식(AZN)의 최신 뉴스

pulisher
Sep 03, 2025

Mineralys (MLYS) Steals Spotlight From AstraZeneca, Reaches Fresh Peak - Yahoo Finance

Sep 03, 2025
pulisher
Sep 03, 2025

AstraZeneca PLC Depositary Receipt stock trend outlook and recovery path2025 Valuation Update & Fast Exit Strategy with Risk Control - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Will AstraZeneca PLC Depositary Receipt price bounce be sustainableJuly 2025 Fed Impact & Consistent Profit Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What’s AstraZeneca PLC Depositary Receipt’s historical returnJuly 2025 Summary & Stepwise Trade Signal Guides - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Is AstraZeneca PLC Depositary Receipt reversing from oversold territory2025 Winners & Losers & Low Risk Entry Point Guides - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Can AstraZeneca PLC Depositary Receipt lead its sector in growthWeekly Trend Summary & Trade Opportunity Analysis Reports - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Can machine learning forecast AstraZeneca PLC Depositary Receipt recoveryGold Moves & Verified Momentum Stock Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Just over £119 now, AstraZeneca’s share price looks cheap to me anywhere under £220.91 - uk.finance.yahoo.com

Sep 03, 2025
pulisher
Sep 03, 2025

What technical models suggest about AstraZeneca PLC Depositary Receipt’s comeback - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Is AstraZeneca PLC Depositary Receipt a defensive stock2025 Volatility Report & Free Expert Approved Momentum Trade Ideas - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Mineralys surges after late-stage trial data AstraZeneca’s blood pressure drug - Seeking Alpha

Sep 02, 2025
pulisher
Sep 02, 2025

What momentum shifts mean for AstraZeneca PLC Depositary ReceiptTrade Risk Assessment & Smart Allocation Stock Tips - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

What institutional flow reveals about AstraZeneca PLC Depositary ReceiptEntry Point & Stock Market Timing Techniques - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

What MACD and RSI say about AstraZeneca PLC Depositary ReceiptShare Buyback & Verified Momentum Stock Watchlist - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

What are AstraZeneca PLC Depositary Receipt’s recent SEC filings showingDividend Hike & AI Based Trade Execution Alerts - خودرو بانک

Sep 02, 2025
pulisher
Sep 02, 2025

Detecting price anomalies in AstraZeneca PLC Depositary Receipt with AITrend Reversal & Expert Approved Momentum Ideas - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Verdion signs AstraZeneca to Stockholm logistics park - Green Street News

Sep 02, 2025
pulisher
Sep 02, 2025

AstraZeneca's Latest Drug Offers Hope For Millions Battling Hard-To-Control Blood Pressure - Yahoo Finance

Sep 02, 2025
pulisher
Sep 02, 2025

FibroGen Completes Sale of Chinese Subsidiary to AstraZeneca - MarketScreener

Sep 02, 2025
pulisher
Sep 02, 2025

AstraZeneca reports total voting rights of 1.55 billion ordinary shares - Investing.com

Sep 02, 2025
pulisher
Sep 02, 2025

AstraZeneca: Buy This Pharma Star Now For Upside Potential - Seeking Alpha

Sep 02, 2025
pulisher
Sep 01, 2025

Can AstraZeneca PLC Depositary Receipt deliver alphaJuly 2025 Analyst Calls & Technical Pattern Based Buy Signals - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Real time scanner hits for AstraZeneca PLC Depositary Receipt explainedJuly 2025 Big Picture & Expert Curated Trade Setup Alerts - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

AstraZeneca Announces Current Share Capital and Voting Rights - TipRanks

Sep 01, 2025
pulisher
Sep 01, 2025

AstraZeneca’s baxdrostat shows promise in Phase III hypertension trial - Clinical Trials Arena

Sep 01, 2025
pulisher
Sep 01, 2025

Published on: 2025-09-01 16:47:49 - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Can trapped investors hope for a rebound in AstraZeneca PLC Depositary ReceiptMarket Activity Summary & Technical Pattern Based Buy Signals - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

AstraZeneca Shares (LON:AZN) Higher: Strong Baxdrostat Data - AskTraders.com

Sep 01, 2025
pulisher
Sep 01, 2025

AstraZeneca to seek approval for new drug which could deliver $5 billion annual sales, 1 Sep 2025 11:43 - Shares Magazine

Sep 01, 2025
pulisher
Sep 01, 2025

What candlestick patterns are forming on AstraZeneca PLC Depositary ReceiptPortfolio Return Report & High Yield Equity Trading Tips - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

After this weekend’s news, is it time to look again at the AstraZeneca share price? - MSN

Sep 01, 2025
pulisher
Sep 01, 2025

Signal strength of AstraZeneca PLC Depositary Receipt stock in tech scannersEarnings Recap Report & Long-Term Safe Investment Ideas - Newser

Sep 01, 2025
pulisher
Aug 31, 2025

Multi asset correlation models including AstraZeneca PLC Depositary ReceiptPortfolio Performance Report & Reliable Entry Point Trade Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

How to recover losses in AstraZeneca PLC Depositary Receipt stockJuly 2025 Reactions & Community Supported Trade Ideas - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

AstraZeneca's Hypertension Drug Lowers Blood Pressure in 'Meaningful, Sustained' Manner - MarketScreener

Aug 31, 2025
pulisher
Aug 31, 2025

AstraZeneca | Pharmaceuticals, Vaccines, & Facts - Britannica

Aug 31, 2025
pulisher
Aug 30, 2025

Technical analysis overview for AstraZeneca PLC Depositary Receipt stock2025 Volume Leaders & Technical Confirmation Trade Alerts - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Shareholders that lost money on AstraZeneca PLC (AZN) should contact Levi & Korsinsky about pending Class ActionAZN - ACCESS Newswire

Aug 30, 2025
pulisher
Aug 30, 2025

AstraZeneca’s New Study on T-DXd Offers Hope for HER2-Positive Tumor Patients - MSN

Aug 30, 2025
pulisher
Aug 30, 2025

AstraZeneca is said to seek approval for antihypertensive this year - Seeking Alpha

Aug 30, 2025
pulisher
Aug 30, 2025

AstraZeneca Faces Close Race With Mineralys After Phase III Hypertension Readout - insights.citeline.com

Aug 30, 2025
pulisher
Aug 30, 2025

15.7mmHg Blood Pressure Reduction: AstraZeneca's Novel Drug Shows Breakthrough in Treatment-Resistant HTN - Stock Titan

Aug 30, 2025
pulisher
Aug 30, 2025

AstraZeneca to seek approval for blood pressure drug by year-end - MarketScreener

Aug 30, 2025
pulisher
Aug 30, 2025

AstraZeneca PLC Depositary Receipt Included in Top Momentum ScanJuly 2025 Update & Technical Pattern Based Signals - beatles.ru

Aug 30, 2025
pulisher
Aug 30, 2025

What does recent volatility data suggest for AstraZeneca PLC Depositary Receipt2025 Trade Ideas & Technical Buy Zone Confirmations - Newser

Aug 30, 2025
pulisher
Aug 29, 2025

Using Ichimoku Cloud for AstraZeneca PLC Depositary Receipt technicalsWeekly Trade Summary & Free AI Powered Buy and Sell Recommendations - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

Is it time to cut losses on AstraZeneca PLC Depositary ReceiptWeekly Trade Report & Safe Capital Growth Plans - Newser

Aug 29, 2025
자본화:     |  볼륨(24시간):